Catheter ablation for atrial fibrillation is a minimally invasive procedure performed in an electrophysiology (EP) lab. Its primary goal is to eliminate the arrhythmia and restore a normal heart rhythm.
The main heart chamber responsible for atrial fibrillation is the left atrium. The pulmonary veins, which carry oxygenated blood from the lungs, empty into this chamber. These veins play a critical role in atrial fibrillation, as the abnormal electrical triggers that provoke the arrhythmia are located at their openings (ostia).
The procedure is performed in a hospital’s electrophysiology laboratory by cardiologists who specialize in the interventional management of heart rhythm disorders (electrophysiologists), working alongside specialized technicians and nursing staff. The treatment aims to restore and maintain a normal sinus rhythm, reduce atrial fibrillation recurrences, manage symptoms, and ultimately improve the patient’s quality of life.
Numerous clinical trials have demonstrated that catheter ablation is significantly more effective at maintaining a normal heart rhythm than available antiarrhythmic drug therapies. It currently stands as the most powerful therapeutic tool we have to free patients from atrial fibrillation and restore a normal rhythm.
Which Patients Are Candidates for Ablation?
Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting 2-3% of the general population. Its prevalence increases with age, affecting approximately 300,000 people in Greece. Today, ablation therapy is offered to a much broader spectrum of patients than in the past, yielding highly beneficial outcomes.
Catheter ablation is indicated in the following cases:
Paroxysmal Atrial Fibrillation
This refers to the form of the arrhythmia where episodes come on suddenly, last less than 7 days (usually from a few minutes up to 24 hours), and stop on their own (spontaneously) without medical intervention.
- Patients with multiple episodes that cause symptoms despite being on antiarrhythmic medication.
Persistent Atrial Fibrillation
This refers to the form of the arrhythmia where an episode lasts continuously for more than 7 days. In these cases, the arrhythmia does not stop on its own and requires medical intervention—either through medication or electrical cardioversion—to restore a normal rhythm.
- Patients who remain symptomatic despite medical therapy, or those who have undergone previous cardioversions but continue to experience recurrences. In persistent AF, ablation significantly reduces the overall "burden" of the arrhythmia on the heart and provides substantial symptom relief.
First-Line Therapy (Without Prior Drug Trials)
- Patients with symptomatic atrial fibrillation who have not yet tried antiarrhythmic medications. This includes individuals who prefer a more definitive treatment over lifelong medication, or those for whom drug therapy is likely to cause, or has already caused, significant side effects. For instance, patients with underlying slow heart rates (bradycardia) cannot tolerate antiarrhythmic drugs, as these medications further slow down an already sluggish heart rate. Implementing a pacemaker solely to allow the continuation or up-titration of these drugs is a practice now discouraged by current clinical guidelines; our duty is to treat the root cause of the problem. Furthermore, amiodarone is not recommended as a first-line choice for paroxysmal atrial fibrillation unless other medications are contraindicated and the patient cannot undergo ablation.
Heart Failure
- Patients with heart failure and a reduced left ventricular ejection fraction whose clinical decline is attributed to atrial fibrillation. Clinical trials have shown that these patients benefit immensely from ablation, experiencing fewer hospital admissions and a significant increase in overall survival.
Patient Age
Regarding age, strict limitations no longer apply. Particularly with the introduction of Pulsed Field Ablation (PFA), the clinical data shows a much lower risk of procedural complications. Patient selection—even for individuals over 80–85 years of age—is now based on a comprehensive assessment of their overall comorbidities rather than age alone.
Asymptomatic Patients
We typically select patients for ablation who are experiencing symptoms. In patients who report no symptoms (asymptomatic), we carefully weigh the adverse long-term effects of leaving the arrhythmia untreated. However, careful history-taking or a trial restoration of normal rhythm is necessary to confirm that a patient is truly asymptomatic, as many slowly adapt to a lower functional capacity. If a decline in cardiac function is found to be caused by the arrhythmia—even in the absence of obvious symptoms—catheter ablation is our most powerful tool and should be performed.
Which Patients DO NOT Need Catheter Ablation?
- Patients with permanent (long-standing) atrial fibrillation whose heart rate is well-controlled with simple medications and who remain entirely symptom-free.
- Patients with severe, life-limiting co-existing medical conditions that would make undergoing the ablation procedure itself unacceptably risky.
Preparing for the Procedure
The ablation procedure does not require elaborate preparation on the patient’s part. Generally, careful attention is paid to the following:
- As a rule, patients taking blood thinners (anticoagulants) do not stop their medication. If you take a newer direct oral anticoagulant (DOAC) prescribed once daily [such as Rivaroxaban (Xarelto)], you will take your dose as normal the day before. If you take a DOAC prescribed twice daily [such as Dabigatran (Pradaxa) or Apixaban (Eliquis)], you will take your normal evening dose the night before and follow your physician’s specific instructions regarding the morning dose on the day of the procedure. If you take vitamin K antagonists (such as Sintrom or Panwarfin), you will continue your medication and have your INR level checked on the morning of the procedure.
- Routine non-cardiac medications typically do not need to be paused. Regarding antiarrhythmic medications, your physician will advise you in advance whether to continue or temporarily stop them.
- You must fast from midnight or the morning of the procedure (a normal dinner the night before is perfectly fine).
- Shortly before the procedure, a transesophageal echocardiogram (TEE) is performed to definitively rule out any blood clots in the left atrium. If a clot is detected, the procedure is postponed, and intensive anticoagulant therapy is managed to dissolve it.
The Ablation Procedure
Most commonly, the procedure is performed under general anesthesia or deep sedation ("twilight anesthesia") to ensure the patient experiences absolutely no discomfort or pain.
Initially, diagnostic catheters are inserted through the venous system (via the femoral veins in the groin) into the heart to record internal electrical activity. Usually, one catheter is placed in the coronary sinus and potentially another near the Bundle of His. Following this, a long sheath and a specialized needle are advanced through the right femoral vein to perform a transseptal puncture of the fossa ovalis, granting safe access to the left atrium.
Depending on the patient’s specific anatomical and clinical characteristics, the electrophysiologist will choose one of the following ablation methods. However, in recent years, pulsed field energy has become the gold standard for first-time ablations:
- Pulsed Field Ablation (PFA): This represents the most advanced technique available today and is rapidly gaining widespread adoption. The catheter delivers high-intensity, ultra-short electrical pulses that cause electrical inactivation of the target heart cells. PFA is uniquely tissue-selective for the myocardium, meaning it leaves adjacent structures—such as the esophagus and the phrenic nerve—completely unharmed. Current data indicates that PFA is more effective and durable than traditional thermal energy sources (RF and Cryoballoon).
- Radiofrequency Ablation (RF / Point-by-Point): This method utilizes a circular or multipolar mapping catheter for recording and an ablation catheter that generates heat to create precise tissue scars (cauterization). With the assistance of an advanced 3D mapping system, a real-time model of the left atrium is constructed. The physician creates circumferential lines around the openings of the four pulmonary veins to achieve complete electrical isolation. Today, this method is most frequently reserved for repeat procedures where detailed mapping is required to touch up gaps.
- Cryoballoon Ablation: A specialized balloon catheter is advanced to block the opening of each pulmonary vein, freezing the tissue at ultra-low temperatures to achieve electrical isolation. While this method offers shorter procedure times, it lacks the ability to map complex arrhythmias and is gradually being phased out as it is superseded by Pulsed Field Ablation.
After the Procedure
The patient returns to the recovery ward, where they must remain flat in bed, taking care during the first few hours not to make sudden movements with the leg that was used for vascular access. Patients are usually able to get out of bed 4-5 hours later. The following morning, an electrocardiogram (ECG) and an echocardiogram (ultrasound) are performed, after which the patient is discharged from the hospital.
Most patients can return to work two days after discharge, though we advise waiting one week before resuming strenuous physical activity (gym workouts, intense sports). Blood thinners must be continued for at least two months, after which long-term therapy is evaluated based on your overall stroke risk profile. Antiarrhythmic medications may be continued for 2-3 months to prevent early, temporary irritation-related recurrences (the blanking period) or stopped altogether.
Both before and after the procedure, strict management of underlying risk factors (controlling blood pressure, weight loss, avoiding alcohol, treating sleep apnea, and optimizing heart failure management) is vital to maximize long-term success.
What Is the Expected Outcome of Ablation?
The primary expected outcome is the long-term maintenance of a normal heart rhythm. Success rates are highest for paroxysmal AF, slightly lower for persistent AF, and lowest for long-standing persistent AF (>1 year).
For paroxysmal atrial fibrillation, the long-term success rate with a single procedure is roughly 50-60%, rising to 80-90% if a touch-up procedure is performed. In persistent forms, traditional success rates using radiofrequency energy ranged between 60-75% and 50-60%, respectively. However, contemporary clinical trials demonstrate that the newer Pulsed Field Ablation (PFA) method yields substantially higher and more stable success rates by ensuring more durable vein isolation without tissue gaps.
Even if a recurrence occurs, episodes are typically far less frequent, shorter, and much easier to manage with medications that may have previously failed. If an organized atrial tachycardia (a fast rhythm related to the healing process) develops after the procedure, it can be highly successfully treated with a repeat ablation.
Are There Risks Involved?
Catheter ablation is exceptionally safe. The international complication rate ranges between 1% and 3% and is statistically inversely proportional to the center’s volume and experience. Across our 24 years of experience (2002–2026), our rate of serious complications remains below 1%, with the majority tied to older techniques that have since been modernized.
Potential complications include:
- Groin hematoma: A collection of blood at the puncture site. These resolve on their own and are virtually eliminated today by using ultrasound guidance to gain vascular access.
- Cardiac tamponade: Fluid accumulation around the heart. This is managed immediately in the lab via a small drainage needle. The use of modern contact-force sensing catheters and performing the transseptal puncture under intracardiac or transesophageal ultrasound guidance significantly helps prevent this issue.
- Stroke (~0.2%): Thorough intraprocedural management and strict adherence to blood thinners make this an extremely rare event.
- Atrio-esophageal fistula and pulmonary vein stenosis: Severe complications seen in the past that are now completely avoided due to modern techniques and the non-thermal nature of Pulsed Field Ablation (PFA).
- Phrenic nerve injury: A temporary weakness of the diaphragm that used to be a risk with the Cryoballoon, but is non-existent with PFA.
Technological Advances in Recent Years
Over our two-decade history, rapid technological milestones have given us a clear therapeutic upper hand. High-density 3D mapping, contact-force catheters, advanced cryoballoons, and most notably, Pulsed Field Ablation (PFA) have elevated both efficacy and safety profiles. This safety net allows us to confidently treat elderly patients or those with multiple health issues (such as heart failure), offering them a meaningful return to health.
Frequently Asked Questions
- I have atrial fibrillation. Do I need to have an ablation? If you have symptoms, ablation offers far superior outcomes compared to drug therapy. For very mild symptoms, lifestyle modifications can be trialed first, but the final decision should be reached in close consultation with your cardiologist.
- Can I know my specific success rate beforehand? The highest success rates are expected in younger patients with paroxysmal AF who have no other heart conditions. Factors like significant left atrial enlargement, continuous persistent AF (>1 year), and comorbidities like diabetes or coronary artery disease typically predict lower success rates. However, even in persistent AF, we see excellent reductions in overall arrhythmia burden, which protects long-term heart health.
- Can I stop taking my blood thinners after a successful ablation? Anticoagulants are mandatory for at least 2 months post-procedure. Their long-term discontinuation is determined by your individual stroke risk profile (CHA₂DS₂-VASc score) because asymptomatic, unnoticed episodes of AF can still pose a clot risk.However, established scientific evidence from large, randomized clinical trials—specifically the ALONE-AF and OCEAN studies—demonstrates that stopping anticoagulation can be a clinically safe option for specific patient groups. Based on the framework of these studies, discontinuation can be considered if the following strict criteria are met:
- You have completed at least 1 full year (12 months) post-ablation without any documented arrhythmia recurrence.
- You undergo rigorous, regular rhythm monitoring (via Holter monitors or wearable tracking devices) to objectively confirm the continuous maintenance of a normal rhythm.
- You fall into a low-to-moderate thromboembolic risk category (typically a CHA₂DS₂-VASc score of 1 to 3), matching the profiles of the patients validated in those trials.
The data from these trials confirms that stopping blood thinners in these highly selected individuals significantly reduces major bleeding risks without increasing stroke rates. Conversely, for high-risk patients (CHA₂DS₂-VASc >3 or with a history of stroke), lifelong anticoagulation remains necessary.
- What is the best ablation method? The best technique is the one tailored to your unique clinical profile. Today, Pulsed Field Ablation (PFA) stands out as the most advanced, first-choice method.
- Will I need to take antiarrhythmic drugs after the ablation? The ultimate goal is to get you off rhythm-control medications entirely. They may be used protectively for the first 2-3 months, and in some cases, drugs that were useless before the ablation become completely effective afterward.
- I want to do the procedure, but I am terrified of complications. Thanks to PFA and high-resolution 3D imaging, the risk of a serious complication in experienced centers approaches zero. The procedural risk is statistically far lower than the long-term risks of leaving AF untreated (heart failure, stroke, dementia) or the side effects of decades of strong heart medications.
- Why do some ablations fail? During the natural healing tissue process, the body can sometimes create microscopic gaps in the treatment lines, allowing abnormal signals to cross back over. Alternatively, triggers outside the pulmonary veins that were dormant during the first procedure may become active later on.
- If the procedure is unsuccessful, can it be repeated? Yes, it can safely be performed more than once if necessary, specifically targeting areas where electrical conduction has recovered, alternative trigger sites, or organized atrial tachycardia circuits.
- Can the procedure cause any adverse effects years down the road? No, long-term registries show no late negative effects. On the contrary, maintaining a normal rhythm through ablation improves long-term survival and provides strong protection against cognitive decline, dementia, and embolic strokes.